Anemia of malignancy

E. P. Frenkel, R. L. Bick, C. J. Rutherford

Research output: Contribution to journalArticlepeer-review

10 Scopus citations


Anemia is a common association of malignant disease. It may be the first diagnostic clue to an underlying malignant disease, it may contribute to the patient's symptoms from the disease, and it may affect treatment decisions. It is important to recognize that a number of underlying mechanisms may contribute to the anemia, and to exclude those that are treatable. The recognition that tumor-associated cytokine production is a major factor in the anemia of malignancy, and that recombinant EPO can overcome this suppression, are major steps forward.

Original languageEnglish (US)
Pages (from-to)861-874
Number of pages14
JournalHematology/Oncology Clinics of North America
Issue number4
StatePublished - 1996

ASJC Scopus subject areas

  • Hematology
  • Oncology


Dive into the research topics of 'Anemia of malignancy'. Together they form a unique fingerprint.

Cite this